BioCentury
ARTICLE | Company News

Sequenom sales and marketing update

April 1, 2013 7:00 AM UTC

Sequenom's Sequenom Center for Molecular Medicine launched the Heredi-T laboratory-developed test (LDT) to analyze a patient's risk of being a cystic fibrosis carrier. The non-invasive test analyzes 1...